Ascendis Pharma to Report Full Year 2023 Financial Results and Provide Business Update on February 7, 2024
COPENHAGEN, Denmark, Jan. 31, 2024 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq:ASND) today announced it will report full year 2023 financial results and provide a business update on Wednesday, February 7, 2024, after the close of the U.S. financial markets. Ascendis Pharma will also host a conference call and webcast on February 7, 2024, at 4:30 p.m. Eastern Time (ET) to discuss 2023 financial results.
Related news for (ASND)
- Ascendis Pharma Reports Fourth Quarter and Full Year 2023 Results
- Ascendis Pharma to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
- Ascendis Pharma Launches 2nd TransCon™ Product: YORVIPATH® Now Available in Germany and Austria for Adults with Chronic Hypoparathyroidism
- New Company Eyconis Formed to Develop Ascendis Pharma Ophthalmology Assets with $150 Million Commitment from External Investors